drugset / Trial / NCT00406380
Effect of Avastin in Juxtafoveal Telangiectasias
Non-randomizedFactorialOpen-labelTreatment
Summary
Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias
Timeline
- Start
- 2006-09
- Primary completion
- 2006-09
- Completion
- 2006-11
Outcome
Outcome not reported
Stopped: “Undefined”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 2.5 mg | Intravitreal |